Note 11 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration Paid for the VersaPharm Acquisition and the Fair Value of the Acquired Assets and Assumed Liabilities (USD $)				0 Months Ended										0 Months Ended
	Sep. 30, 2014	Aug. 12, 2014	Dec. 31, 2013	Aug. 12, 2014 Cash Paid To VersaPharm Stockholder [Member] VersaPharm [Member]	Aug. 12, 2014 Cash Paid To VersaPharm Option Holders [Member] VersaPharm [Member]	Aug. 12, 2014 Cash Paid To Escrow [Member] VersaPharm [Member]	Aug. 12, 2014 Cash Paid To Paid To Previous Owners Of VersaPharm [Member] VersaPharm [Member]	Aug. 12, 2014 Equity Consideration Paid At Closing [Member] VersaPharm [Member]	Aug. 12, 2014 Debt Payoff [Member] VersaPharm [Member]	Aug. 12, 2014 IPR&D [Member] VersaPharm [Member]	Aug. 12, 2014 Trademarks [Member] VersaPharm [Member]	Aug. 12, 2014 Licensing Agreements [Member] VersaPharm [Member]	Aug. 12, 2014 Other Intangible Assets [Member] VersaPharm [Member]	Aug. 12, 2014 VersaPharm [Member]
Note 11 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Consideration Paid for the VersaPharm Acquisition and the Fair Value of the Acquired Assets and Assumed Liabilities [Line Items]
Payments to Acquire Business				$ 322,700,000	$ 14,200,000	$ 10,300,000	$ 3,400,000	$ 350,600,000	$ 82,400,000					$ 433,000,000
Cash and cash equivalents														100,000
Accounts receivable														10,000,000
Inventory														20,900,000
Other current assets														2,800,000
Property and equipment														1,500,000
Intangible											1,000,000	250,800,000	5,200,000
IPR&D										215,900,000
Goodwill	290,648,000		29,831,000											90,600,000
Total assets acquired														598,800,000
Assumed current liabilities														(18,300,000)
Assumed non-current liabilities														(76,000,000)
Deferred tax liabilities														(153,900,000)
Total liabilities assumed														(248,200,000)
		$ 350,600,000